Empagliflozin as add‐on to linagliptin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52‐week, randomized, placebo‐controlled trial
Kawamori, Ryuzo, Haneda, Masakazu, Suzaki, Keiko, Cheng, Gang, Shiki, Kosuke, Miyamoto, Yuki, Solimando, Fernando, Lee, Christopher, Lee, Jisoo, George, Jyothis
Published in Diabetes, obesity & metabolism (01.09.2018)
Published in Diabetes, obesity & metabolism (01.09.2018)
Get full text
Journal Article
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial
Kaku, Kohei, Haneda, Masakazu, Tanaka, Yuko, Lee, Ganghyuck, Shiki, Kosuke, Miyamoto, Yuki, Solimando, Fernando, Lee, Jisoo, Lee, Christopher, George, Jyothis
Published in Diabetes, obesity & metabolism (01.01.2019)
Published in Diabetes, obesity & metabolism (01.01.2019)
Get full text
Journal Article